APLS
Price
$23.15
Change
-$0.99 (-4.10%)
Updated
Oct 14 closing price
Capitalization
2.92B
26 days until earnings call
Intraday Buy/Sell Signals
DYN
Price
$15.45
Change
+$1.42 (+10.12%)
Updated
Oct 14 closing price
Capitalization
2.2B
15 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

APLS vs DYN

Header iconAPLS vs DYN Comparison
Open Charts APLS vs DYNBanner chart's image
Apellis Pharmaceuticals
Price$23.15
Change-$0.99 (-4.10%)
Volume$1.46M
Capitalization2.92B
Dyne Therapeutics
Price$15.45
Change+$1.42 (+10.12%)
Volume$2.2M
Capitalization2.2B
APLS vs DYN Comparison Chart in %
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. DYN commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and DYN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (APLS: $23.15 vs. DYN: $15.45)
Brand notoriety: APLS and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 65% vs. DYN: 93%
Market capitalization -- APLS: $2.92B vs. DYN: $2.2B
APLS [@Biotechnology] is valued at $2.92B. DYN’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 3 bullish TA indicator(s).

  • APLS’s TA Score: 5 bullish, 6 bearish.
  • DYN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, APLS is a better buy in the short-term than DYN.

Price Growth

APLS (@Biotechnology) experienced а -8.17% price change this week, while DYN (@Biotechnology) price change was +10.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

APLS is expected to report earnings on Nov 10, 2025.

DYN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($2.92B) has a higher market cap than DYN($2.2B). APLS YTD gains are higher at: -27.452 vs. DYN (-34.423). APLS has higher annual earnings (EBITDA): -178.43M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. APLS (370M). DYN has less debt than APLS: DYN (121M) vs APLS (470M). APLS has higher revenues than DYN: APLS (755M) vs DYN (0).
APLSDYNAPLS / DYN
Capitalization2.92B2.2B133%
EBITDA-178.43M-437.37M41%
Gain YTD-27.452-34.42380%
P/E RatioN/AN/A-
Revenue755M0-
Total Cash370M684M54%
Total Debt470M121M388%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSDYN
RSI
ODDS (%)
Bullish Trend 8 days ago
81%
Bearish Trend 8 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 8 days ago
85%
Momentum
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 8 days ago
81%
MACD
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
85%
Bullish Trend 8 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 21 days ago
80%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
Aroon
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 8 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMUGX26.240.25
+0.96%
MFS Utilities R1
RSMOX24.670.10
+0.41%
Victory RS Mid Cap Growth A
WFDAX27.270.06
+0.22%
Allspring SMID Cap Growth Fund - Cl A
SCIIX7.180.01
+0.14%
Virtus SGA International Growth A
VAFIX35.35-0.47
-1.31%
Invesco American Franchise Y

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-4.10%
DNLI - APLS
49%
Loosely correlated
+1.54%
DYN - APLS
43%
Loosely correlated
+10.12%
VTYX - APLS
41%
Loosely correlated
-1.62%
ARWR - APLS
41%
Loosely correlated
-0.80%
OCUL - APLS
41%
Loosely correlated
-5.23%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+10.12%
RNA - DYN
58%
Loosely correlated
-1.70%
XNCR - DYN
58%
Loosely correlated
-10.96%
CRNX - DYN
53%
Loosely correlated
-0.86%
OCUL - DYN
52%
Loosely correlated
-5.23%
SYRE - DYN
52%
Loosely correlated
+11.02%
More